NCT05600634 Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
| NCT ID | NCT05600634 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Condition | Kidney Transplant Rejection |
| Study Type | OBSERVATIONAL |
| Enrollment | 24 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 24 participants in total. It began in 2024-01-01 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study was to explore the accuracy of sentinel skin grafts from the same donor source in diagnosing renal allograft rejection, and to provide new ideas and options for the later clinical diagnosis of renal allograft rejection. Further, try to provide timing guidance for early immunization intervention.
Eligibility Criteria
Inclusion Criteria: 1. Patients with end-stage renal disease undergoing renal transplantation; 2. 18-60 years old; 3. Postoperative follow-up points are complete (visit the hospital every week in the first month after surgery, every two weeks in 2-3 months, every four to six months, and every three months in 7-12 months. Follow up at any time when skin rejection is observed. The follow-up time may be adjusted when the condition changes); 4. The participants had good compliance, volunteered to participate in the test and signed the informed consent form. Exclusion Criteria: 1. Untreated or disseminated malignant tumor; 2. Active period of infectious diseases; 3. Serious cardiovascular disease occurred recently; 4. Combined with other important organ failure; 5. History of mental illness or cognitive impairment;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05600634 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Kidney Transplant Rejection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05600634 currently recruiting?
Yes, NCT05600634 is actively recruiting participants. Contact the research team at cwar@163.com for enrollment information.
Where is the NCT05600634 trial being conducted?
This trial is being conducted at Xi'an, China, Hangzhou, China, Hangzhou, China.
Who is sponsoring the NCT05600634 clinical trial?
NCT05600634 is sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. The trial plans to enroll 24 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.